[Mechanism of ginsenoside Rg1 regulating the activity of β secretase in N2a/APP695 cells].Ginsenoside Rg1 decreases Aβ(1-42) level by upregulating PPARγ and IDE expression in the hippocampus of a rat model of Alzheimer's disease.Bioactive constituents from the roots of Panax japonicus var. major and development of a LC-MS/MS method for distinguishing between natural and artifactual compounds.Multi-faced neuroprotective effects of Ginsenoside Rg1 in an Alzheimer mouse model.Ginsenoside Rg1 attenuates oligomeric Aβ(1-42)-induced mitochondrial dysfunction.The effects and mechanism of ginsenoside Rg1 on myocardial remodeling in an animal model of chronic thromboembolic pulmonary hypertension.The beneficial effect of ginsenoside Rg1 on Schwann cells subjected to hydrogen peroxide induced oxidative injury.Activating glucocorticoid receptor-ERK signaling pathway contributes to ginsenoside Rg1 protection against β-amyloid peptide-induced human endothelial cells apoptosis.Ginsenoside Rg1 inhibits autophagy in H9c2 cardiomyocytes exposed to hypoxia/reoxygenation.Ginsenoside Rg1 protects human fibroblasts against psoralen- and UVA-induced premature senescence through a telomeric mechanism.Ginsenoside Rg1 promotes glucose uptake through activated AMPK pathway in insulin-resistant muscle cells.The ginsenoside Rg1 prevents transverse aortic constriction-induced left ventricular hypertrophy and cardiac dysfunction by inhibiting fibrosis and enhancing angiogenesis.[Effects of ginsenoside Rg1 on the expressions of p-eRK1/2 and p-JNK in local cerebral ischemia/reperfusion injury rats].Estrogenic effect of ginsenoside Rg1 on APP processing in post-menopausal platelets.Involvement of IGF-I receptor and estrogen receptor pathways in the protective effects of ginsenoside Rg1 against Aβ₂₅₋₃₅-induced toxicity in PC12 cells.Ginsenoside Rg1 facilitates neural differentiation of mouse embryonic stem cells via GR-dependent signaling pathway.Long-term ginsenoside Rg1 supplementation improves age-related cognitive decline by promoting synaptic plasticity associated protein expression in C57BL/6J mice.Ginsenoside Rg1 attenuates concanavalin A-induced hepatitis in mice through inhibition of cytokine secretion and lymphocyte infiltration.Ginsenoside Rg1 improves survival in a murine model of polymicrobial sepsis by suppressing the inflammatory response and apoptosis of lymphocytes.Purification method improvement and characterization of a novel ginsenoside-hydrolyzing beta-glucosidase from Paecilomyces Bainier sp. 229.Improvement of ginsenoside Rg1 on hematopoietic function in cyclophosphamide-induced myelosuppression mice.Ginsenoside Rg1 attenuates okadaic acid induced spatial memory impairment by the GSK3β/tau signaling pathway and the Aβ formation prevention in rats.MicroRNA-15b contributes to ginsenoside-Rg1-induced angiogenesis through increased expression of VEGFR-2.Effect of ginsenoside Rg1 on proliferation and differentiation of human dental pulp cells in vitro.Ginsenoside Rg1 attenuates high glucose-induced endothelial barrier dysfunction in human umbilical vein endothelial cells by protecting the endothelial glycocalyxGinsenoside Rg1 Accelerates Paracrine Activity and Adipogenic Differentiation of Human Breast Adipose-Derived Stem Cells in a Dose-Dependent Manner In Vitro[Ginsenoside Rg1 antagonizes β-amyloid peptide-induced apoptosis in primarily cultured rat neurons via mitochondrial pathway][Tissue distribution of ginsenoside Rg1 before and after modification by PEG]Ginsenoside Rg1 reduces toxicity of PM(2.5) on human umbilical vein endothelial cells by upregulating intracellular antioxidative state
P921
Q34227272-B5768186-41DD-447D-BEC8-342ED27BE4E6Q34632017-3DE1E394-E457-4E52-8814-D5CFB49D5C5FQ34973863-18D00310-B3AC-4CFD-8CB5-4B0462BD2836Q35831048-B3496407-7703-44CD-AF99-CE0C1EF6D40BQ36054716-2BDE610A-9D0E-4D9F-A4B1-A40B82577E9DQ36926549-1EBD66DD-8CED-427E-A88E-9C007E2E102BQ37001525-23E49BA7-E46B-4E9D-B1F6-F393170F90E3Q39174095-2EC20916-9088-4C0B-96E0-DAE1B58BB31CQ39251472-AE139DB6-9E45-4052-A0F4-5B80D1DE93D8Q39393473-3D9417EE-9B0C-4970-B1ED-C8DDA5E3FCEDQ39428276-0C1EF267-9FB8-4E7B-B4A0-C7F306E16D61Q43556528-BE3DE5CB-59A9-4BE7-913D-0EF0D5E3F187Q43975689-8DE63A77-75B0-4E58-A2A5-6A1A44F55F7DQ44478325-6A0C6FBA-7BEA-4034-9C1F-D562B5160837Q44575309-E1FE21C6-3F3F-4756-930D-5B4B81C348CDQ45395764-DDB254F4-22AB-4759-A880-895CA0AA5B22Q45423585-183312E8-3A41-43B0-AAA4-EB9CB9D2DAB7Q46032244-FCBD20A0-017D-4B57-BCA2-6E57925ABCADQ46148301-1EDF5BCE-77DF-430A-9958-A97527C3C231Q46767578-CBE6726A-8D7B-48BF-8B44-066838DBC3C2Q48618763-653E0651-2914-43BC-ACB1-4A0A3F6D5208Q50748602-572A91E4-2441-4EF5-BCF7-CCD70496D5B7Q50979370-15AFAE31-2D55-41A6-AA32-CB4897160B14Q51778985-E0E990AB-CBB5-40E5-ADD9-19CD727C1A45Q64097687-7CD58A41-E635-4D52-8F4E-ADC5DAD4BDDAQ64271024-33F8DFCC-EAD7-4CE0-A0C0-2FD1B46CC86DQ84882694-20AB24E5-9700-41EB-906A-9DBD58B930EEQ85010976-15200DFC-955D-4E3C-AD7E-37DE01B66767Q85642754-F7E5B5F0-EA7E-4BEB-9AD7-C11D57AFC241
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Ginsenoside
@it
Ginsenoside
@nl
Ginsenozid Rg1
@sh
Ginsenozid Rg1
@sr
Ginsenósido
@es
ginsenoside Rg1
@en
ginsénosides
@ar
جینسنوسید
@fa
จินเซนโนไซด์
@th
ギンセノサイト
@ja
type
label
Ginsenoside
@it
Ginsenoside
@nl
Ginsenozid Rg1
@sh
Ginsenozid Rg1
@sr
Ginsenósido
@es
ginsenoside Rg1
@en
ginsénosides
@ar
جینسنوسید
@fa
จินเซนโนไซด์
@th
ギンセノサイト
@ja
altLabel
(3beta,6alpha,12beta)-3,12-dihydroxydammar-24-ene-6,20-diyl bis-beta-D-glucopyranoside
@en
Ginsenoside A2
@en
Ginsenoside Rg1
@en
Ginsenosido
@es
Panaxoside A
@en
Panaxoside Rg1
@en
Rg1
@en
Sanchinoside C1
@en
Sanchinoside Rg1
@en
beta-D-Glucopyranoside, (3beta,6alpha,12beta)-3,12-dihydroxy dammar-24-ene-6,20-diylbis-
@en
prefLabel
Ginsenoside
@it
Ginsenoside
@nl
Ginsenozid Rg1
@sh
Ginsenozid Rg1
@sr
Ginsenósido
@es
ginsenoside Rg1
@en
ginsénosides
@ar
جینسنوسید
@fa
จินเซนโนไซด์
@th
ギンセノサイト
@ja
P4964
P6689
P486
P592
P646
P661
P662
P665
P683
P2017
CC(=CCC[C@@](C)([C@H]1CC[C@@]2 ...... @H]([C@@H]([C@H](O6)CO)O)O)O)C
P2057
HMDB0035857
P2064
P2067
800.492207
P231
22427-39-0
P232
P233
CC(=CCCC(C)(C1CCC2(C1C(CC3C2(C ...... C)O)C)OC6C(C(C(C(O6)CO)O)O)O)C
P234
1S/C42H72O14/c1-20(2)10-9-13-4 ...... ,36+,37-,39+,40+,41+,42-/m0/s1
P235
YURJSTAIMNSZAE-HHNZYBFYSA-N
P2566
100.040.884